Page last updated: 2024-08-24

gemcitabine and apatinib

gemcitabine has been researched along with apatinib in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	3 (60.00)	2.80

Authors

Authors	Studies
Bao, YT; Li, CM; Liu, ZC; Sun, XD; Wang, LL	1
Hu, C; Hui, K; Jiang, X; Liang, L; Qiao, Y; Ren, Y; Wang, L; Xia, Y; Zhu, P	1
Cheng, X; Li, Y; Tian, Y	1
Chen, MY; Ding, X; Duan, CY; Gu, CM; Hua, YJ; Huang, PY; Liu, YL; Liu, YP; Ouyang, YF; Wang, X; Wang, ZQ; Xu, HS; You, R; Zhang, MX; Zhang, WJ; Zou, X	1
Hu, W; Li, K; Liu, K; Qu, L	1

Reviews

1 review(s) available for gemcitabine and apatinib

Article	Year
Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review. World journal of gastroenterology, 2017, Nov-07, Volume: 23, Issue:41 Topics: Angiogenesis Inhibitors; Antigens, Tumor-Associated, Carbohydrate; Chemoradiotherapy; Deoxycytidine; Disease-Free Survival; Fatal Outcome; Female; Gemcitabine; Humans; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Pleural Effusion, Malignant; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyridines; Tomography, X-Ray Computed; Treatment Failure; Vascular Endothelial Growth Factor Receptor-2	2017

Article

Year

Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review.

World journal of gastroenterology, 2017, Nov-07, Volume: 23, Issue:41

Topics: Angiogenesis Inhibitors; Antigens, Tumor-Associated, Carbohydrate; Chemoradiotherapy; Deoxycytidine; Disease-Free Survival; Fatal Outcome; Female; Gemcitabine; Humans; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Pleural Effusion, Malignant; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyridines; Tomography, X-Ray Computed; Treatment Failure; Vascular Endothelial Growth Factor Receptor-2

2017

Trials

1 trial(s) available for gemcitabine and apatinib

Article	Year
Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer. Computational intelligence and neuroscience, 2022, Volume: 2022 Topics: Deoxycytidine; Gallbladder Neoplasms; Gemcitabine; Humans; Immunity; Oxaliplatin; Pyridines; Retrospective Studies	2022

Other Studies

3 other study(ies) available for gemcitabine and apatinib

Article	Year
Apatinib concurrent gemcitabine for controlling malignant ascites in advanced pancreatic cancer patient: A case report. Medicine, 2017, Volume: 96, Issue:47 Topics: Antineoplastic Agents; Ascites; Deoxycytidine; Drug Therapy, Combination; Gemcitabine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Protein-Tyrosine Kinases; Pyridines; Vascular Endothelial Growth Factor Receptor-2	2017
Chemotherapy combined with apatinib for the treatment of desmoplastic small round cell tumors: A case report. Journal of cancer research and therapeutics, 2020, Volume: 16, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Desmoplastic Small Round Cell Tumor; Epirubicin; Gemcitabine; Humans; Male; Neoplasm Metastasis; Oncogene Proteins, Fusion; Pyridines; RNA-Binding Protein EWS; Treatment Outcome; Vincristine; WT1 Proteins	2020
Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma. Med (New York, N.Y.), 2022, 10-14, Volume: 3, Issue:10 Topics: Antibodies, Monoclonal, Humanized; Circulating Tumor DNA; Clinical Trials as Topic; Deoxycytidine; Endothelial Growth Factors; Gemcitabine; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Pyridines	2022